<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>sci comm | Jennifer Jahncke</title>
    <link>/tag/sci-comm/</link>
      <atom:link href="/tag/sci-comm/index.xml" rel="self" type="application/rss+xml" />
    <description>sci comm</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Thu, 28 May 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/img/logo.JPEG</url>
      <title>sci comm</title>
      <link>/tag/sci-comm/</link>
    </image>
    
    <item>
      <title>Immunohistochemistry: Adding Color to the Brain</title>
      <link>/project/immunohistochemistry/</link>
      <pubDate>Thu, 28 May 2020 00:00:00 +0000</pubDate>
      <guid>/project/immunohistochemistry/</guid>
      <description>


&lt;p&gt;Have you ever wondered how we make these bright and beautiful images of proteins in the brain? It‚Äôs done using a technique called immunohistochemistry, which we also call IHC or immuno. The technique used antibodies to label proteins in fixed tissue.&lt;/p&gt;
&lt;center&gt;
&lt;img src=&#34;collage.jpg&#34; style=&#34;width:80.0%&#34; /&gt;
&lt;/center&gt;
&lt;p&gt;First, I preserve the brain using formaldehyde. This ‚Äúfixes‚Äù the proteins in place. I then embed the brain in a block of agar and slice it into thin sections. There are several ways to do this but I use a vibrating razor blade.&lt;/p&gt;
&lt;video width=&#34;400&#34; style=&#34;display:block; margin:0 auto;&#34; controls&gt;
&lt;source src=&#34;vibratome.mp4&#34; type=&#34;video/mp4&#34;&gt;
&lt;/video&gt;
&lt;p&gt;Now I split up my sections into different wells. Each well will contain a different combination of antibodies so that I can label different proteins.&lt;/p&gt;
&lt;center&gt;
&lt;img src=&#34;12-well-plate.JPG&#34; style=&#34;width:80.0%&#34; /&gt;
&lt;/center&gt;
&lt;p&gt;The combination of antibodies matters. I need a primary antibody, which recognizes my protein of interest, and a secondary antibody which latches on to the primary antibody. The secondary antibody contains a fluorescent ‚Äútag‚Äù. This tag is what the microscope sees.&lt;/p&gt;
&lt;center&gt;
&lt;img src=&#34;primary.jpg&#34; style=&#34;width:80.0%&#34; /&gt;
&lt;/center&gt;
&lt;p&gt;In order to look at multiple proteins in the same tissue section, I can use other fluorescent tags that emit different wavelengths of light.&lt;/p&gt;
&lt;center&gt;
&lt;img src=&#34;primary%20and%20secondary.jpg&#34; style=&#34;width:80.0%&#34; /&gt;
&lt;/center&gt;
&lt;p&gt;You‚Äôll notice that all of my images only have 3-4 different colors in them. That‚Äôs because we need to be able to separate the fluorescent tags. If the emitted light of two tags have wavelengths that are too close together we cannot tell them apart.&lt;/p&gt;
&lt;center&gt;
&lt;img src=&#34;all%20spectra%20ex%20em.PNG&#34; style=&#34;width:90.0%&#34; /&gt;
&lt;/center&gt;
&lt;p&gt;Okay, so I have my antibodies where I want them. Now I mount the tissue sections onto microscope slides and they‚Äôre ready to be imaged on the microscope!&lt;/p&gt;
&lt;center&gt;
&lt;img src=&#34;slide-on-scope.JPG&#34; style=&#34;width:60.0%&#34; /&gt;
&lt;/center&gt;
&lt;p&gt;The microscope images one ‚Äúchannel‚Äù of fluorescence at a time. In this case I used 4 different antibodies for 4 different proteins. (The numbers in the parentheses are the wavelengths of the emitted light from the fluorescent tag.)&lt;/p&gt;
&lt;center&gt;
&lt;img src=&#34;single%20channels.jpg&#34; style=&#34;width:100.0%&#34; /&gt;
&lt;/center&gt;
&lt;p&gt;Now I can overlay the images on one another to get that beautiful merged image. The coloring in the merged image doesn‚Äôt necessarily correspond to the fluorescent tags I used. I can use any color combination I want. These four images are all the same micrograph.&lt;/p&gt;
&lt;center&gt;
&lt;img src=&#34;merge.jpg&#34; style=&#34;width:90.0%&#34; /&gt;
&lt;/center&gt;
&lt;p&gt;And that‚Äôs it! Each step has additional intricacies that I glossed over for the sake of simplicity. There are also a number of different microscopy methods that could be used. These images were all taken using a Zeiss Axio Imager equipped with an apotome system.&lt;/p&gt;
&lt;p&gt;Wanna talk about it? &lt;a href=&#34;https://twitter.com/thejenjay/status/1262832430886469632?s=20&#34;&gt;Hit up my Twitter thread&lt;/a&gt;.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Microscope Me Up: Purkinje Cells</title>
      <link>/project/microscope-me-up-purkinje-cells/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>/project/microscope-me-up-purkinje-cells/</guid>
      <description>



</description>
    </item>
    
    <item>
      <title>A Thread: Molecular Mechanisms of Non-ionotropic LTD</title>
      <link>/project/a-thread-non-ionotropic-nmda-receptor-signaling/</link>
      <pubDate>Fri, 10 Jan 2020 00:00:00 +0000</pubDate>
      <guid>/project/a-thread-non-ionotropic-nmda-receptor-signaling/</guid>
      <description>


&lt;div align=&#34;center&#34;&gt;
&lt;blockquote class=&#34;twitter-tweet&#34;&gt;
&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;
Preprint featuring one of the projects I worked on during my time as a research assistant! Here we start to put together the molecular signaling pathway downstream of non-ionotropic LTD and spine shrinkage. &lt;a href=&#34;https://t.co/MBSfExBzih&#34;&gt;https://t.co/MBSfExBzih&lt;/a&gt;
&lt;/p&gt;
‚Äî Jennifer Jahncke (&lt;span class=&#34;citation&#34;&gt;@thejenjay&lt;/span&gt;) &lt;a href=&#34;https://twitter.com/thejenjay/status/1215690681508757505?ref_src=twsrc%5Etfw&#34;&gt;January 10, 2020&lt;/a&gt;
&lt;/blockquote&gt;
&lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;
&lt;/div&gt;
&lt;div align=&#34;center&#34;&gt;
.
&lt;/div&gt;
&lt;p&gt;Brain cells form excitatory synaptic connections on structures called dendritic spines. These spines change size/shape as the synapse strenghtens or weakens. This process is known as synaptic plasticity. One form of synaptic plasticity is long-term depression (LTD) in which the synapse weakens and the spine shrinks. The mechanism by which LTD occurs is often taught as being an ‚Äúionotropic‚Äù process - meaning that it requires the movement of ions. In the case of LTD, calcium flux through the NMDA receptor has been shown over and over again to be crucial. Glutamate binds to the NMDA receptor, calcium fluxes into the cell and binds PP2B/calcineurin, which dephosphorylates AMPA receptors, leading to AMPA receptor endocytosis and synaptic weakening.&lt;/p&gt;
&lt;div align=&#34;center&#34;&gt;
&lt;img src=&#34;ionotropic-ltd.PNG&#34; style=&#34;width:50.0%&#34; /&gt;
&lt;/div&gt;
&lt;p&gt;But what is non-ionotropic LTD? To understand this process you first need to know something about NMDA receptors: they require TWO agonists for the ion pore to open: (1) glutamate and (2) glycine or D-serine. If glutamate binds the receptor in the absence of the co-agonist the pore does not open and no calcium can flow through.&lt;/p&gt;
&lt;div align=&#34;center&#34;&gt;
&lt;img src=&#34;co-agonists.png&#34; style=&#34;width:70.0%&#34; /&gt;
&lt;/div&gt;
&lt;p&gt;Recently-ish (Nabavi et al., 2013) it was found that if glutamate binds WITHOUT the ion pore opening‚Ä¶.LTD can still occur. ü§Ø (PS - yes, recently-ish was 6-7 years ago‚Ä¶)&lt;/p&gt;
&lt;div align=&#34;center&#34;&gt;
&lt;img src=&#34;navabi.png&#34; /&gt;
&lt;/div&gt;
&lt;p&gt;But there‚Äôs no calcium influx! So what is going on? Some FRET experiments showed that the intracellular tails of the NMDA receptor move in response to glutamate binding, even in the absence of a co-agonist. This certainly smells like metabotropic signaling. But people didn‚Äôt like calling it metabotropic because NMDA receptors are ionotropic‚Ä¶fine‚Ä¶we‚Äôll call it non-ionotropic signaling.&lt;/p&gt;
&lt;div align=&#34;center&#34;&gt;
&lt;img src=&#34;metabotropic.PNG&#34; style=&#34;width:30.0%&#34; /&gt;
&lt;/div&gt;
&lt;p&gt;Before our paper, the only known players in the non-ionotropic signaling pathway were p38 MAPK, CaMKII, and PP1. Here we parse out the signaling pathway, linking NMDA receptor agonism and the associated conformational change to AMPA receptor endocytosis.&lt;/p&gt;
&lt;div align=&#34;center&#34;&gt;
&lt;img src=&#34;pp1-camkii.jpg&#34; /&gt;
&lt;/div&gt;
&lt;p&gt;Our paper uses 2-photon glutamate uncaging to induce LTP at single spines. This results in reduced synaptic strength (assayed with electrophyiology) and spine shrinkage. We then blocked potential signaling molecules and looked to see if this also blocked spine shrinkage.&lt;/p&gt;
&lt;div align=&#34;center&#34;&gt;
&lt;img src=&#34;nNOS.png&#34; /&gt;
&lt;/div&gt;
&lt;p&gt;Indeed, we found that CaMKII, nNOS, NOS1AP, p38 MAPK, MK2, and cofilin were all necessary for non-ionotropic spine shrinkage!&lt;/p&gt;
&lt;div align=&#34;center&#34;&gt;
&lt;p&gt;&lt;img src=&#34;featured.PNG&#34; style=&#34;width:50.0%&#34; /&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Update:&lt;/strong&gt; This paper has since been &lt;a href=&#34;https://www.jneurosci.org/content/40/19/3741&#34;&gt;published at J. Neuro!&lt;/a&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&#34;references&#34; class=&#34;section level4&#34;&gt;
&lt;h4&gt;References:&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Kauer, J., Malenka, R. Synaptic plasticity and addiction. Nat Rev Neurosci 8, 844‚Äì858 (2007). &lt;a href=&#34;https://doi.org/10.1038/nrn2234&#34; class=&#34;uri&#34;&gt;https://doi.org/10.1038/nrn2234&lt;/a&gt;&lt;br /&gt;
&lt;/li&gt;
&lt;li&gt;Valdivielso, J.M., Eritja, A., Caus, M., Bozic, M. Glutamate-Gated NMDA Receptors: Insights into the Function and Signaling in the Kidney. Biomolecules 10 (7), 1051 (2020). &lt;a href=&#34;https://doi.org/10.3390/biom10071051&#34; class=&#34;uri&#34;&gt;https://doi.org/10.3390/biom10071051&lt;/a&gt;&lt;br /&gt;
&lt;/li&gt;
&lt;li&gt;Nabavi S, Kessels HW, Alfonso S, Aow J, Fox R, Malinow R. Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression. Proc Natl Acad Sci U S A. 2013;110(10):4027-4032. &lt;a href=&#34;https://doi.org/10.1073/pnas.1219454110&#34; class=&#34;uri&#34;&gt;https://doi.org/10.1073/pnas.1219454110&lt;/a&gt;&lt;br /&gt;
&lt;/li&gt;
&lt;li&gt;Aow J, Dore K, Malinow R. Conformational signaling required for synaptic plasticity by the NMDA receptor complex. Proc Natl Acad Sci U S A. 2015;112(47):14711-14716. &lt;a href=&#34;https://doi.org/10.1073/pnas.1520029112&#34; class=&#34;uri&#34;&gt;https://doi.org/10.1073/pnas.1520029112&lt;/a&gt;&lt;br /&gt;
&lt;/li&gt;
&lt;li&gt;Dore K, Aow J, Malinow R. Agonist binding to the NMDA receptor drives movement of its cytoplasmic domain without ion flow. Proc Natl Acad Sci U S A. 2015;112(47):14705-14710. &lt;a href=&#34;doi:10.1073/pnas.1520023112&#34; class=&#34;uri&#34;&gt;doi:10.1073/pnas.1520023112&lt;/a&gt;&lt;br /&gt;
&lt;/li&gt;
&lt;li&gt;Stein IS, Park DK, Flores JC, Jahncke JN, Zito K. Molecular Mechanisms of Non-ionotropic NMDA Receptor Signaling in Dendritic Spine Shrinkage. J Neurosci. 2020;40(19):3741-3750. &lt;a href=&#34;doi:10.1523/JNEUROSCI.0046-20.2020&#34; class=&#34;uri&#34;&gt;doi:10.1523/JNEUROSCI.0046-20.2020&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Soph Talks Science: Cellfie of the Month Sept 2019</title>
      <link>/project/soph-talks-science-sep-2019/</link>
      <pubDate>Mon, 02 Sep 2019 00:00:00 +0000</pubDate>
      <guid>/project/soph-talks-science-sep-2019/</guid>
      <description>



</description>
    </item>
    
  </channel>
</rss>
